226 related articles for article (PubMed ID: 18408926)
1. Molecular mechanisms of MHC class I abnormalities and APM components in human tumors.
Seliger B
Cancer Immunol Immunother; 2008 Nov; 57(11):1719-26. PubMed ID: 18408926
[TBL] [Abstract][Full Text] [Related]
2. Different regulation of MHC class I antigen processing components in human tumors.
Seliger B
J Immunotoxicol; 2008 Oct; 5(4):361-7. PubMed ID: 19404870
[TBL] [Abstract][Full Text] [Related]
3. Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases.
D'Alicandro V; Romania P; Melaiu O; Fruci D
Mol Immunol; 2019 Sep; 113():11-15. PubMed ID: 29625843
[TBL] [Abstract][Full Text] [Related]
4. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
Dhatchinamoorthy K; Colbert JD; Rock KL
Front Immunol; 2021; 12():636568. PubMed ID: 33767702
[TBL] [Abstract][Full Text] [Related]
5. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
[TBL] [Abstract][Full Text] [Related]
6. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
[TBL] [Abstract][Full Text] [Related]
7. The role of classical and non-classical HLA class I antigens in human tumors.
Bukur J; Jasinski S; Seliger B
Semin Cancer Biol; 2012 Aug; 22(4):350-8. PubMed ID: 22465194
[TBL] [Abstract][Full Text] [Related]
8. IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.
Lorenzi S; Forloni M; Cifaldi L; Antonucci C; Citti A; Boldrini R; Pezzullo M; Castellano A; Russo V; van der Bruggen P; Giacomini P; Locatelli F; Fruci D
PLoS One; 2012; 7(10):e46928. PubMed ID: 23071666
[TBL] [Abstract][Full Text] [Related]
9. Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin.
Seliger B; Wollscheid U; Momburg F; Blankenstein T; Huber C
Tissue Antigens; 2000 Oct; 56(4):327-36. PubMed ID: 11098932
[TBL] [Abstract][Full Text] [Related]
10. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
12. Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.
Reimann J; Böhm W; Schirmbeck R
Biol Chem Hoppe Seyler; 1994 Nov; 375(11):731-6. PubMed ID: 7535058
[TBL] [Abstract][Full Text] [Related]
13. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells.
Hengel H; Esslinger C; Pool J; Goulmy E; Koszinowski UH
J Gen Virol; 1995 Dec; 76 ( Pt 12)():2987-97. PubMed ID: 8847504
[TBL] [Abstract][Full Text] [Related]
14. HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant Disease.
Seliger B; Ferrone S
Methods Mol Biol; 2020; 2055():325-350. PubMed ID: 31502159
[TBL] [Abstract][Full Text] [Related]
15. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
[TBL] [Abstract][Full Text] [Related]
16. The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors.
Seliger B
J Immunotoxicol; 2014 Oct; 11(4):308-10. PubMed ID: 24479372
[TBL] [Abstract][Full Text] [Related]
17. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
Montealegre S; van Endert PM
Front Immunol; 2018; 9():3098. PubMed ID: 30666258
[TBL] [Abstract][Full Text] [Related]
18. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
[TBL] [Abstract][Full Text] [Related]
19. MHC class I antigens, immune surveillance, and tumor immune escape.
Garcia-Lora A; Algarra I; Garrido F
J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MHC class I antigen presentation by viral proteins.
Früh K; Ahn K; Peterson PA
J Mol Med (Berl); 1997 Jan; 75(1):18-27. PubMed ID: 9020380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
